A Response to the Letter to the Editor: "Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?" [0.03%]
对《编辑部来信“我们能在真实世界中确定一线治疗晚期ALK阳性NSCLC患者的更佳标准吗？”》的回复
Vincent K Lam,Shirish M Gadgeel
Vincent K Lam
Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World? [0.03%]
我们能在真实世界中为ALK阳性晚期NSCLC患者的一线治疗制定更佳标准吗？
Edyta Maria Urbanska,Jens Benn Sørensen,Eric Santoni-Rugiu
Edyta Maria Urbanska
A Response to the Letter to the Editor: "Quality Performance Indicators for Lung Cancer Screening: Towards the Next Levels?" [0.03%]
对《论肺部癌症筛查质量绩效指标的来信》的回复：“迈向下一水平？”
Martin C Tammemägi,Andrea Borondy-Kitts,John F Field et al.
Martin C Tammemägi et al.
Quality Performance Indicators for Lung Cancer Screening: Towards the Next Levels? [0.03%]
肺癌筛查的质量性能指标：迈向下一阶段？
Jan Van Meerbeeck,Guido Van Hal,Annemiek Snoeckx
Jan Van Meerbeeck
A Response to the Letter to the Editor: "Enhancing Radiomics Clustering: Nonlinear and Nonparametric Approaches in Biological Data Analysis" [0.03%]
论答：利用非线性和非参数方法增强生物数据中的放射组学聚类分析能力
Hong-Ji Li,Zhen-Bin Qiu,Meng-Min Wang et al.
Hong-Ji Li et al.
Enhancing Radiomics Clustering: Nonlinear and Nonparametric Approaches in Biological Data Analysis [0.03%]
改进的放射组学聚类：生物数据分析中的非线性和非参数方法
Yoshiyasu Takefuji
Yoshiyasu Takefuji
Old Wine in New Bottles? Deuterium Switch (Replacing Hydrogen With Deuterium) Comes to Thoracic Oncology as Deuterated Lorlatinib (Deulorlatinib, TGRX-326) and Deuterated Osimertinib (Asandeutertinib, TY-9591) in ALK+ NSCLC and EGFR+ NSCLC, Respectively [0.03%]
旧酒装新瓶？去氢化洛拉替尼（德氯elelatinib，TGRX-326）和去氢奥希替尼（andasertinib，TY-9591）在ALK+ NSCLC 和 EGFR+ NSCLC 肺癌中的研究进展
Cathleen June Park,Molly Siu-Ching Li,Sai-Hong Ignatius Ou
Cathleen June Park
Overcoming Barriers to Lung Cancer Screening: The Incidental Pulmonary Nodule Strategy [0.03%]
突破肺癌筛查障碍：意外发现肺结节策略
Marie-Pierre Revel
Marie-Pierre Revel
Bridging the Gap in Surgery for Octogenarians With Early-Stage Lung Cancer [0.03%]
bridging the gap in surgery for octogenarians with early-stage lung cancer老年人早期肺癌手术的缺口及对策
Fangqiu Fu,Haiquan Chen
Fangqiu Fu
Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Biomarker For "Cold" Tumor? [0.03%]
STK11、KEAP1和SMARCA4基因拷贝丢失：冷肿瘤的生物标志物吗？
Sita Andarini,Jamal Zaini
Sita Andarini